Clariant believes it can grow International Flavors & Fragrances’ cosmetic ingredients business, principally Lucas Meyer active ingredients, functional ingredients and delivery systems, from $100m in sales annually to $180m by 2028. IFF will use proceeds from that and other recent divestures to pay down debt.
Swiss specialty chemical company Clariant AG will position itself as a leader in the high-value cosmetic ingredients space and expand its footprint in North America with its planned purchase of International Flavors & Fragrances, Inc.’s cosmetic ingredients business.
Expected to close in the fourth quarter subject to regulatory approvals and customary closing conditions, the firm agreed to pay...
Following Energy and Commerce Health Subcommittee hearing about FDA’s human food and tobacco programs on 10 September, gap between what the trade groups, committee leadership and the FDA each want more of doesn’t appear to be shrinking.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Global beauty giant is working to adapt its approach to the prestige market to meet escalating competition, increased points of sale, and more knowledgeable consumers with new shopping habits, CFO Tracey Travis said at the Barclays Global Consumer Staples Conference.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
